Cost-effectiveness of Commercial or Traditional Fecal Microbiota Transplantation for Recurrent Clostridioides difficile Infection
Listen to this summary
The authors aimed to evaluate the cost-effectiveness of commercial, FDA-approved microbiota therapeutics compared to traditional fecal microbiota transplantation (FMT) via colonoscopy for managing recurrent Clostridioides difficile infection (rCDI). Their findings indicate that traditional FMT is the most cost-effective strategy, with an incremental cost-effectiveness ratio of $44,158, while commercial microbiota therapeutics are not cost-effective when donor-derived FMT is available. Overall, the study concludes that colonoscopic FMT remains the optimal approach for preventing subsequent rCDI episodes.
This is one of 33,000+ journals available on OSLR. Try it free for 14 days.
Free 14-day trial. 33,000+ journals. Cancel anytime.

More from Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
View all →Jun 12, 2026 · Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Clinical Impact of the BIOFIRE® FILMARRAY® Pneumonia Panel in the Veterans Affairs Healthcare System: A Difference-in-Differences Study
Jun 11, 2026 · Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Oral Wash PCR Improves the Diagnosis of Pneumocystis Pneumonia in Immunocompromised Patients Without HIV: A Prospective Multicenter Study
More in Pediatrics
View all →Nov 20, 2026 · Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Effect of a Multidisciplinary Intervention on Fatigue in Lymphoma Survivors With Persistent Fatigue: A Randomized Controlled Trial (the REFUEL trial).
Nov 20, 2026 · Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Reach of State-Mandated Insurance Coverage for Fertility Preservation in Patients With Cancer.
Nov 20, 2026 · Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Alectinib as Neoadjuvant Treatment in Potentially Resectable Stage III Anaplastic Lymphoma Kinase-Positive Non-Small Cell Lung Cancer: ALNEO Phase II Trial (GOIRC-01-2020-ML42316).
Nov 20, 2026 · Hormone research in paediatrics
Post-Menarcheal Height Gain After Gonadotropin-Releasing Hormone Agonist Treatment in Girls with Central Precocious Puberty.
Nov 20, 2026 · Hormone research in paediatrics
JUVENILE IDIOPATHIC ARTHRITIS IN CHILDREN WITH TYPE 1 DIABETES: IMPACT OF CURRENT MEDICAL TREATMENT OPTIONS ON ANTHROPOMETRY AND METABOLIC CONTROL.
Nov 20, 2026 · European heart journal
Acute pulmonary embolism: long-term cause-specific mortality in a Chinese nationwide registry.
"Oslr has become part of my weekly routine on my day off. The clinical relevance of the summaries is outstanding — I'd rate it 9/10. Being able to consume research hands-free is a huge advantage for busy physicians."
Dr. Jennifer Thompson
Portland, OR


